Differential Diagnostics of
Hyperuricaemia in Hereditary Metabolic Diseases
Stibůrková B.1, Šebesta I.1, 4, Pospíšilová E.1, Šťastná S.1, Kumšta M.4, Zeman J.1, Kmoch S.1, 2
1Ústav dědičných poruch metabolismu 1. LF UK, Praha 2Centrum integrované genomiky, Praha 3Klinika dětského a dorostového lékařství 1. LF UK a VFN, Praha 4Ústav klinické biochemie 1. LF UK a VFN, Praha |
|
Summary:
Objective: Hyperuricaemia is a frequent laboratory finding in children and adults, in a wide range of acquired or
genetically-based metabolic diseases. Among the most frequent reasons for hyperuricaemia is excessive production
of purines de novo, accelerated degradation or decreased interconversions of purine nucleotides and decreased renal
excretion of uric acid.
Setting: Institute of Inherited Metabolic Disorders, General Faculty Hospital and Charles University First Faculty of
Medicine.
Material and Method: Within the scope of selective screening for inherited metabolic disorders conducted from 1995 till
2002 in the Czech Republic, blood and/or urine level of the uric acid was investigated approximately in 17 000 cases
in a group of 24 000 patients. Purine metabolites had been monitored in 3 000 patients.
Results: Various inherited metabolic disorders as the reason for hyperuricaemia were found in 82 patients. Twenty
patients suffered from familial juvenile hyperuricaemic nephropathy. Deficient activity of hypoxantine-guaninephosphoribosyltransferase
was found in 14 patients, glycogenosis type I in 20, glycogenosis type III in 5, glykogenosis type VI
in 4 and glykogenosis type IX in 19 patients.
Conclusions: Differential diagnostics of patients suffering hyperuricemia is rather wide and in order to correctly discover
the diagnosis a cooperation with specialized laboratory is necessary. Metabolic, enzymatic and molecular analyses
may significantly contribute both to the recognition of the etiology of hyperuricemia and to the monitoring of the
patient’s compliance.
Key words:
hyperuricaemia, hypoxanthin phosphoribosyltransferase, Lesch-Nyhan syndrome, phosphoribosylpyrophosphate
synthetase (ribose-phosphate pyrophosphokinase), glykogen storage disease, familial juvenile hyperuricaemic
nephropathy.
|